QA – Page 15 – Pharma.Tips

EM Excursion Investigation for Viable and Non-Viable Particles

Investigating Environmental Monitoring Deviations for Particle Contamination In pharmaceutical manufacturing, deviations from established environmental monitoring protocols, particularly regarding viable and non-viable particles, pose significant risks. Such deviations can lead to…

How to Investigate Failed Swab Results with Passing Rinse Data

Step-by-Step Guide to Investigating Failed Swab Results Alongside Rinse Data In pharmaceutical manufacturing and quality control environments, discrepancies between swab and rinse sampling results can pose significant challenges. Identifying the…

Original data misunderstandings in batch manufacturing records: Practical ALCOA+ Controls for GMP Teams

Understanding and Implementing ALCOA+ Principles in Batch Manufacturing Records In the pharmaceutical manufacturing environment, maintaining data integrity is crucial for compliance with regulatory expectations and ensuring product quality. A common…

Environmental Monitoring Deviation Due to Personnel Gowning Failure

Addressing Environmental Monitoring Deviations Arising from Personnel Gowning Failure In the pharmaceutical manufacturing environment, maintaining strict control over contamination is essential for compliance with Good Manufacturing Practices (GMP). One alarming…

Rinse Sampling Volume Justification for GMP Cleaning Studies

Justifying Rinse Sampling Volume in GMP Cleaning Studies In the realm of pharmaceutical manufacturing, ensuring effective cleaning processes is pivotal. A common challenge encountered is the determination of suitable rinse…

Original data misunderstandings in QC laboratory records: Practical ALCOA+ Controls for GMP Teams

Addressing Data Misunderstandings in QC Laboratory Records Using ALCOA+ Principles In the realm of pharmaceutical manufacturing, data integrity remains paramount, especially within QC laboratory settings. Discrepancies or misunderstandings in laboratory…

How to Investigate Recurring Microbial Counts in Cleanroom Hotspots

Effective Investigation of Recurring Microbial Counts in Cleanroom Areas In the pharmaceutical industry, maintaining the highest standards of cleanliness is crucial for ensuring product quality and patient safety. However, environmental…

Swab Sampling Locations for Worst-Case Cleaning Validation

Addressing Challenges in Swab vs Rinse Sampling for Cleaning Validation In pharmaceutical manufacturing, ensuring effective cleaning processes is critical to maintaining product quality and regulatory compliance. One of the persistent…

Contemporaneous recording gaps in computerized systems: Practical ALCOA+ Controls for GMP Teams

Addressing Gaps in Computerized Systems Documentation: Effective ALCOA+ Controls for GMP Teams In the regulated pharmaceutical industry, maintaining data integrity is crucial. Gaps in contemporaneous recording within computerized systems can…

Environmental Monitoring Trend Deviations: When Alert Levels Become Serious

When Environmental Monitoring Alerts Signal Serious Deviations In pharmaceutical manufacturing, maintaining a controlled environment is critical to ensuring product quality and compliance. Environmental monitoring deviations can indicate serious underlying issues,…

How Sampling Method Choice Affects MACO Compliance

Understanding the Impact of Sampling Method on MACO Compliance In pharmaceutical manufacturing, adhering to Maximum Allowable Carryover (MACO) limits is crucial for ensuring product quality and patient safety. One of…

Contemporaneous recording gaps in cleaning validation records: Practical ALCOA+ Controls for GMP Teams

Addressing Gaps in Cleaning Validation Records with ALCOA+ Principles In the pharmaceutical manufacturing environment, data integrity is paramount, particularly concerning cleaning validation records. A recent case study highlighted serious issues…